Make institutional-grade clinical intelligence accessible to every science team — unified from the first minute, not assembled from a dozen licenses. We replace siloed registries, manual cross-referencing, and prohibitive price tags with one platform that natively links trials, drugs, devices, and patents in a single knowledge graph.
Make institutional-grade clinical intelligence accessible to every science team — unified from the first minute, not assembled from a dozen licenses. We strip away the friction, fragmentation, and prohibitive price tags of legacy systems and replace them with one platform that natively links trials, drugs, devices, and patents in a single knowledge graph. The visibility that used to demand an institutional budget and a team of analysts — open to anyone.
We're building the operating system for external life-sciences intelligence — the AI-first system of intelligence that sits above the systems of record: every meaningful change surfaced shortly after it happens, classified by impact, and linked across 18+ sources with accuracy we're driving toward 99%+ — verifiable down to the source record. The goal is the fastest, most trusted delivery of competitive truth in the market — portable enough to feed straight into any team's agents, models, and BI tools.
Four structural advantages — and the principles behind them.
Trials, drugs, devices, and patents are natively linked in one knowledge graph. Track an asset from a protocol change to its FDA timeline to its patent cliff in a single click — no cross-referencing five tools, no five separate licenses.
We scan registries throughout the day and flag what changed, classified by impact — Critical, High, Medium. You know within hours what legacy platforms surface days later.
50+ cross-filtering charts turn raw data into a competitive profile you can build live in a meeting — not after hours of pivot tables. Maximum insight, minimum setup.
Your data, your tools. Connect any AI assistant or agent over the open Model Context Protocol (MCP), or export structured 22-sheet relational packages that drop straight into LLMs, data lakes, and BI — no vendor lock-in, no cleanup scripts.
We move away from the data-brokerage model toward intelligence automation — giving the teams who move fastest the visibility they could never afford before.
Institutional-grade competitive visibility without an institutional budget or a team of analysts.
One unified platform replaces a stack of siloed, multi-thousand-dollar modules — current from day one.
Pipeline risk, white-space, and IP-versus-revenue signals with full regulatory context, on demand.

Founder & Architect · IAM & Cybersecurity Leader
A senior IAM, cybersecurity, and pharma-data leader with 15+ years of international experience across Europe and Latin America — building ClinicaLister to turn fragmented public data into trusted, always-current intelligence.
Read the founder's story